Deep Track Capital, LP Novo Cure LTD Transaction History

Deep Track Capital, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$16.15 - $42.35 $40.4 Million - $106 Million	2,500,000 New	2,500,000 $40.4 Million
Q3 2022 Nov 14, 2022	SELL	$67.99 - $89.57 $3.23 Million - $4.26 Million	-47,539 Reduced 3.54%	1,293,761 $98.3 Million
Q2 2022 Aug 12, 2022	BUY	$56.6 - $89.9 $19.3 Million - $30.7 Million	341,300 Added 34.13%	1,341,300 $93.2 Million
Q1 2022 May 16, 2022	BUY	$60.15 - $84.52 $27.1 Million - $38 Million	450,000 Added 81.82%	1,000,000 $82.9 Million
Q4 2021 Feb 14, 2022	BUY	$75.08 - $121.99 $41.3 Million - $67.1 Million	550,000 New	550,000 $41.3 Million

262

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.86B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Deep Track Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Deep Track Capital, LP with notifications on news.